A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis

References

• Ostrom Q, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan J. Epidemiology of gliomas. Cancer Treat Res. 2015;163:1–14. doi:10.1007/978-3-319-12048-5_1
   PubMedGoogle Scholar
• Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016;375(2):263–273. doi:10.1016/j.canlet.2016.01.024
   PubMed Web of Science ®Google Scholar
• Ibarra L, Vilchez M, Caverzán M, Milla Sanabria L. Understanding the glioblastoma tumor biology to optimize photodynamic therapy: from molecular to cellular events. J Neurosci Res. 2021;99(4):1024–1047. doi:10.1002/jnr.24776
   PubMed Web of Science ®Google Scholar
• Andersen B, Miranda C, Hatzoglou V, DeAngelis L, Miller A. Leptomeningeal metastases in glioma: the Memorial Sloan Kettering Cancer Center experience. Neurology. 2019;92(21):e2483–e91. doi:10.1212/wnl.0000000000007529
   PubMed Web of Science ®Google Scholar
• Aldape K, Brindle K, Chesler L, et al. Challenges to curing primary brain tumours. Nat Rev. 2019;16(8):509–520. doi:10.1038/s41571-019-0177-5
   Google Scholar
• Tolan H, Tozan-Beceren A, Sardas S, et al. DNA repair capacity of the colorectal cancer patients and the correlation between the pathological parameters. Niger J Clin Pract. 2019;22(2):194–200. doi:10.4103/njcp.njcp_251_18
   PubMed Web of Science ®Google Scholar
• Damia G, Broggini M. Platinum resistance in ovarian cancer: role of DNA repair. Cancers. 2019;11(1):119. doi:10.3390/cancers11010119
   PubMed Web of Science ®Google Scholar
• Chen X, Chen F, Ren Y, et al. IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2. J Cancer Res Clin Oncol. 2019;145(6):1471–1484. doi:10.1007/s00432-019-02917-z
   PubMed Web of Science ®Google Scholar
• López-Camarillo C, Rincón D, Ruiz-García E, Astudillo-de la Vega H, Marchat L. DNA repair proteins as therapeutic targets in ovarian cancer. Curr Protein Pept Sci. 2019;20(4):316–323. doi:10.2174/1389203719666180914091537
   PubMed Web of Science ®Google Scholar
• Liu K, Jiang YJC. Polymorphisms in DNA repair gene and susceptibility to glioma: a systematic review and meta-analysis based on 33 studies with 15 SNPs in 9 genes. Neurobiology. 2017;37(2):263–274. doi:10.1007/s10571-016-0367-y
   Google Scholar
• Liu Y, Scheurer M, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomark Prev. 2009;18(1):204–214. doi:10.1158/1055-9965.Epi-08-0632
   PubMed Web of Science ®Google Scholar
• Yosunkaya E, Kucukyuruk B, Onaran I, Gurel C, Uzan M, Kanigur-Sultuybek GJ. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg. 2010;24(5):561–565. doi:10.3109/02688697.2010.489655
   PubMed Web of Science ®Google Scholar
• Tang L, Deng L, Bai H, et al. Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas. J Neurooncol. 2018;139(3):563–571. doi:10.1007/s11060-018-2915-4
   PubMed Web of Science ®Google Scholar
• Wang R, Ye X, Zhao X, Liu J, Zhang C. Development of a five-gene signature as a novel prognostic marker in ovarian cancer. Neoplasma. 2019;66(3):343–349. doi:10.4149/neo_2018_180705N447
   PubMed Web of Science ®Google Scholar
• Zheng T, Pang Z, Zhao Z. A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients. Biosci Rep. 2019;39(5). doi:10.1042/bsr20190414
   Web of Science ®Google Scholar
• Zhang D, Zheng Y, Yang S, et al. Identification of a novel glycolysis-related gene signature for predicting breast cancer survival. Front Oncol. 2020;10:596087. doi:10.3389/fonc.2020.596087
   PubMed Web of Science ®Google Scholar
• Sun L, Wu J, Wu Z, et al. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma. Int J Cancer. 2015;136(6):E569–77. doi:10.1002/ijc.29211
   PubMed Web of Science ®Google Scholar
• Zuo S, Dai G, Ren X. Identification of a 6-gene signature predicting prognosis for colorectal cancer. Cancer Cell Int. 2019;19:6. doi:10.1186/s12935-018-0724-7
   PubMed Web of Science ®Google Scholar
• Knijnenburg T, Wang L, Zimmermann M, et al. Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas. Cell Rep. 2018;23(1):239–54.e6. doi:10.1016/j.celrep.2018.03.076
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang J, He K, Zhang J. Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand. J Hematol Oncol. 2019;12(1):43. doi:10.1186/s13045-019-0733-6
   PubMed Web of Science ®Google Scholar
• Tessoulin B, Moreau-Aubry A, Descamps G, et al. Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways. J Hematol Oncol. 2018;11(1):137. doi:10.1186/s13045-018-0679-0
   PubMed Web of Science ®Google Scholar
• Nickoloff J, Jones D, Lee S, Williamson E, Hromas R. Drugging the cancers addicted to DNA repair. J Natl Cancer Inst. 2017;109(11). doi:10.1093/jnci/djx059
   PubMedGoogle Scholar
• O’Connor M. Targeting the DNA damage response in cancer. Mol Cell. 2015;60(4):547–560. doi:10.1016/j.molcel.2015.10.040
   PubMed Web of Science ®Google Scholar
• Armanios M, Blackburn E. The telomere syndromes. Genetics. 2012;13(10):693–704. doi:10.1038/nrg3246
   PubMed Web of Science ®Google Scholar
• Duvic B, Brehélin M. Two major proteins from locust plasma are involved in coagulation and are specifically precipitated by laminarin, a beta-1,3-glucan. Insect Biochem Mol Biol. 1998;28(12):959–967. doi:10.1016/s0965-1748(98)00084-8
   PubMed Web of Science ®Google Scholar
• Fouquerel E, Opresko P. Convergence of the nobel fields of telomere biology and DNA repair. Photochem Photobiol. 2017;93(1):229–237. doi:10.1111/php.12672
   PubMed Web of Science ®Google Scholar
• Jinjia C, Xiaoyu W, Hui S, et al. The use of DNA repair genes as prognostic indicators of gastric cancer. J Cancer. 2019;10(20):4866–4875. doi:10.7150/jca.31062
   PubMed Web of Science ®Google Scholar
• Wang X, Tan C, Ye M, et al. Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer. J Cancer. 2020;11(20):5918–5928. doi:10.7150/jca.46328
   PubMed Web of Science ®Google Scholar
• Li N, Zhao L, Guo C, Liu C, Liu Y. Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma. Cancer Manag Res. 2019;11:7473–7484. doi:10.2147/cmar.s204864
   PubMed Web of Science ®Google Scholar
• Hu B, Liu D, Liu Y, Li Z. DNA repair-based gene expression signature and distinct molecular subtypes for prediction of clinical outcomes in lung adenocarcinoma. Front Med. 2020;7:615981. doi:10.3389/fmed.2020.615981
   Web of Science ®Google Scholar
• Li Y, Ji S, Fu L, Jiang T, Wu D, Meng F. Knockdown of cyclin-dependent kinase inhibitor 3 inhibits proliferation and invasion in human gastric cancer cells. Oncol Res. 2017;25(5):721–731. doi:10.3727/096504016x14772375848616
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang L, Wang Y, et al. Expression of CDC5L is associated with tumor progression in gliomas. Tumour Biol. 2016;37(3):4093–4103. doi:10.1007/s13277-015-4088-5
   PubMedGoogle Scholar
• Moskalev A, Smit-McBride Z, Shaposhnikov M, et al. Gadd45 proteins: relevance to aging, longevity and age-related pathologies. Ageing Res Rev. 2012;11(1):51–66. doi:10.1016/j.arr.2011.09.003
   PubMed Web of Science ®Google Scholar
• Hsu Y, Chen M, Huang T. Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells. Cell Death Dis. 2014;5:e1087. doi:10.1038/cddis.2014.22
   PubMed Web of Science ®Google Scholar
• Hickson I. RecQ helicases: caretakers of the genome. Cancer. 2003;3(3):169–178. doi:10.1038/nrc1012
   PubMed Web of Science ®Google Scholar
• Mendoza-Maldonado R, Faoro V, Bajpai S, et al. The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation. Mol Cancer. 2011;10:83. doi:10.1186/1476-4598-10-83
   PubMed Web of Science ®Google Scholar
• Li Y, Gan S, Ren L, et al. Multifaceted regulation and functions of replication factor C family in human cancers. Am J Cancer Res. 2018;8(8):1343–1355.
   PubMed Web of Science ®Google Scholar
• Ho K, Kuo T, Lee Y, et al. Xanthohumol regulates miR-4749-5p-inhibited RFC2 signaling in enhancing temozolomide cytotoxicity to glioblastoma. Life Sci. 2020;254:117807. doi:10.1016/j.lfs.2020.117807
   PubMed Web of Science ®Google Scholar
• Ubhi T, Brown G. Exploiting DNA replication stress for cancer treatment. Cancer Res. 2019;79(8):1730–1739. doi:10.1158/0008-5472.can-18-3631
   PubMed Web of Science ®Google Scholar
• Pedersen H, Anne Adanma Obara E, Elbæk K, Vitting-Serup K, Hamerlik P. Replication Protein A (RPA) mediates radio-resistance of glioblastoma cancer stem-like cells. Int J Mol Sci. 2020;21(5):1588. doi:10.3390/ijms21051588
   PubMed Web of Science ®Google Scholar
• Kim S, Park E, Joo H, et al. RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress. Cancer Lett. 2014;346(2):249–256. doi:10.1016/j.canlet.2013.12.031
   PubMed Web of Science ®Google Scholar
• Jiang K, Zhi T, Xu W, et al. MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1. Am J Cancer Res. 2017;7(4):784–800.
   PubMed Web of Science ®Google Scholar
• Music D, Dahlrot R, Hermansen S, et al. Expression and prognostic value of the WEE1 kinase in gliomas. J Neurooncol. 2016;127(2):381–389. doi:10.1007/s11060-015-2050-4
   PubMed Web of Science ®Google Scholar
• Caretti V, Hiddingh L, Lagerweij T, et al. WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas. Mol Cancer Ther. 2013;12(2):141–150. doi:10.1158/1535-7163.mct-12-0735
   PubMed Web of Science ®Google Scholar